posted on 2018-08-17, 00:00authored byLeila Peraro, Kirsten L. Deprey, Matthew K. Moser, Zhongju Zou, Haydn L. Ball, Beth Levine, Joshua A. Kritzer
Biotherapeutics are
a promising class of molecules in drug discovery,
but they are often limited to extracellular targets due to their poor
cell penetration. High-throughput cell penetration assays are required
for the optimization of biotherapeutics for enhanced cell penetration.
We developed a HaloTag-based assay called the chloroalkane penetration
assay (CAPA), which is quantitative, high-throughput, and compartment-specific.
We demonstrate the ability of CAPA to profile extent of cytosolic
penetration with respect to concentration, presence of serum, temperature,
and time. We also used CAPA to investigate structure–penetration
relationships for bioactive stapled peptides and peptides fused to
cell-penetrating sequences. CAPA is not only limited to measuring
cytosolic penetration. Using a cell line where HaloTag is localized
to the nucleus, we show quantitative measurement of nuclear penetration.
Going forward, CAPA will be a valuable method for measuring and optimizing
the cell penetration of biotherapeutics.